Biomarker R&D

Firalis invests significantly in research and development projects with a direct link and interest in biomarker science. Prooving itself as a reknown expert of the field, Firalis has become a constantly sought SME partner for several European research consortia, rapidly after the creation of SAFE-T Project (Translational Safety Biomarkers), where Firalis was the initiator and coordinator of public consortium.

Research activities at Firalis include all phases required for development of biomarkers, from discovery up to clinical qualification.

Cardiovascular Biomarker

Drug safety & Efficacy

Patient Stratification

Personalized Medicine

New Biomarker Technology